Gsa Capital Partners LLP Quotient LTD Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 09, 2022	SELL	$0.24 - $1.2 $6,242 - $31,213	-26,011 Reduced 64.39%	14,383 $3,000
Q1 2022 May 11, 2022	BUY	$0.94 - $2.38 $37,970 - $96,137	40,394 New	40,394 $48,000
Q4 2021 Feb 14, 2022	SELL	$1.89 - $3.12 $26,327 - $43,461	-13,930 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.34 - $3.77 $32,596 - $52,516	13,930 New	13,930 $33,000
Q4 2020 Feb 03, 2021	SELL	$4.4 - $7.32 $52,144 - $86,749	-11,851 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$4.38 - $8.35 $51,907 - $98,955	11,851 New	11,851 $61,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.